These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10981035)

  • 21. [Type 2 diabetes mellitus and chronic kidney disease].
    Ponťuch P
    Vnitr Lek; 2017; 63(3):188-192. PubMed ID: 28379021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Angiotensin-converting enzyme inhibitors in the treatment of diabetic nephropathy].
    Sawicki PT; Mühlhäuser I; Berger M
    Dtsch Med Wochenschr; 1994 Sep; 119(38):1298-9. PubMed ID: 7924925
    [No Abstract]   [Full Text] [Related]  

  • 23. Compelling drug indications in diabetic and nondiabetic nephropathy.
    Ritz E; Dikow R; Zeier M
    Curr Hypertens Rep; 2004 Aug; 6(4):293-9. PubMed ID: 15257864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Renoprotective effects of ACE inhibitors and AT1 antagonists on diabetic nephropathy beyond blood pressure control].
    Shionoiri H; Yasuda G; Takizawa T; Shionoiri F
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():394-9. PubMed ID: 15999741
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy: response to Tarnow et al.
    Cooper ME
    Diabetes Care; 2000 Dec; 23(12):1723-4. PubMed ID: 11128340
    [No Abstract]   [Full Text] [Related]  

  • 26. [Detail study of angiotensin-receptor blockade versus ACE-inhibition in type 2 diabetes with nephropathy].
    Nitschmann S; Girndt M; Köhler H
    Internist (Berl); 2005 Aug; 46(8):923-4, 926. PubMed ID: 15990988
    [No Abstract]   [Full Text] [Related]  

  • 27. Detecting and controlling diabetic nephropathy: what do we know?
    Appel G
    Cleve Clin J Med; 2013 Apr; 80(4):209-17. PubMed ID: 23547091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive treatment and mortality in diabetic patients. What is the evidence?
    Sawicki PT; Heise T; Berger M
    Diabetologia; 1997 Jul; 40 Suppl 2():S134-7. PubMed ID: 9248721
    [No Abstract]   [Full Text] [Related]  

  • 29. [Type 2 diabetes and nephropathy--new studies, new treatment strategies?].
    Os I; Stenehjem A; Høieggen A; Draganov B; Jenssen T; Holdaas H
    Tidsskr Nor Laegeforen; 2002 Apr; 122(9):918-20. PubMed ID: 12082835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Considerations on the treatment of incipient diabetic nephropathy (lst of 2 parts)].
    Pérez Blanco FJ; Manzanares L; Moreno G; Cabello MJ
    An Med Interna; 1996 Apr; 13(4):193-7. PubMed ID: 8688481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic nephropathy.
    Goto A
    N Engl J Med; 2002 Sep; 347(12):947-8; author reply 947-8. PubMed ID: 12239270
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
    Crook ED; Preddie DC
    Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual blockade of the renin-angiotensin system in diabetic nephropathy.
    Cooper M; Boner G
    Diabet Med; 2004 Jan; 21 Suppl 1():15-8. PubMed ID: 15088932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of ramipril in the therapy of diabetic nephropathy].
    Dézsi CA
    Orv Hetil; 2014 Feb; 155(7):263-9. PubMed ID: 24509355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy.
    Jacobsen P; Andersen S; Jensen BR; Parving HH
    J Am Soc Nephrol; 2003 Apr; 14(4):992-9. PubMed ID: 12660333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of blood glucose and blood pressure control on progression of diabetic nephropathy].
    Schwarz C; Oberbauer R
    Wien Klin Wochenschr; 2000 Nov; 112(21):907-11. PubMed ID: 11144004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin blockade in type 2 diabetic renal disease.
    Ruilope LM; Luño J
    Kidney Int Suppl; 2002 Dec; (82):S61-3. PubMed ID: 12410857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of angiotensin receptor blockers in diabetic nephropathy.
    Sharma AM; Weir MR
    Postgrad Med; 2011 May; 123(3):109-21. PubMed ID: 21566421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.
    Hovind P; Rossing P; Tarnow L; Smidt UM; Parving HH
    Kidney Int; 2001 Jul; 60(1):277-83. PubMed ID: 11422762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Control of arterial pressure in diabetic nephropathy].
    Luño J; García de Vinuesa S
    Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.